Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome

Georg Griesinger, Silvia Trevisan, Barbara Cometti, Georg Griesinger, Silvia Trevisan, Barbara Cometti

Abstract

Study question: What is the independent contribution of endometrial thickness (EMT) on day of embryo transfer to achieving an ongoing pregnancy and live birth after IVF treatment?

Summary answer: EMT is a poor predictor of IVF success and has only little independent prognostic value.

What is known already: In a number of previous studies, pregnancy rates have been found to be lower in patients with thin endometrium.

Study design size duaration: This is a retrospective analysis of data from two large, randomized phase III studies (conducted in Europe and the USA) comparing s.c. progesterone with vaginal progesterone for luteal phase support. The studies were very similar in design, patient population and outcome, and the study data were combined and analysed on an individual patient level.

Participants/materials setting method: Subjects were infertile patients with an indication for IVF/ICSI, aged between 18 and 42 years, BMI <30 kg/m2, <3 prior ART cycles and ≥ 3 oocytes after controlled ovarian stimulation with GnRH-agonist or GnRH-antagonist. EMT was assessed on day of embryo transfer (n = 1401). The association of EMT and ongoing pregnancy rate was determined by comparison of outcomes by quantiles of EMT. The predictive capacity of EMT for ongoing pregnancy achievement was assessed at each millimeter cut-off. Finally, a regression model was built to determine the contribution of EMT among other confounders, such as age and oocyte numbers, on the likelihood of ongoing pregnancy and live birth.

Main results and the role of chance: In univariate analysis, ongoing pregnancy rates correlate to EMT. In patients above a cut-off of ≥9 mm EMT, the chance of pregnancy was higher as compared to patients with an EMT of 3-8 mm (odds ratio (OR) = 1.69, 95% CI: 1.23-2.35, P = 0.001; sensitivity 88.89%, specificity 17.52%, positive predictive value 39.02%, negative predictive value 72.64% and likelihood ratio 1.08). In multivariate regression analysis, after controlling for trial, female age and oocyte numbers, EMT was a statistically significant predictor of live birth (OR = 1.05, 95% CI: 1.00-1.10; P = 0.0351). If EMT indeed is an independent factor affecting outcome, this finding implies that at a baseline live birth rate of 20% an increase of 2 mm in EMT should result in an increase of the live birth rate of ~1.6%.

Limitations reasons for caution: The independent contribution of EMT to live birth likelihood is small and may result from (undetermined) confounding. The EMT on day of embryo transfer is usually higher as compared to the EMT on day of triggering final oocyte maturation when it is conventionally assessed during routine cycle monitoring. Furthermore, endometrial lining pattern and/or subendometrial Doppler flow have not been assessed and, accordingly, the conclusions of this work are limited to only the thickness of the endometrium.

Wider implications of the findings: EMT can be ignored during cycle monitoring of the majority of IVF patients and only the extremes of EMT deserve further diagnostic work-up.

Study funding/competing interests: The study was supported by IBSA. G.G. has received personal fees and non-financial support from MSD, Ferring, Merck-Serono, Finox, TEVA, IBSA, Glycotope, Abbott, Gedeon-Richter as well as personal fees from VitroLife, NMC Healthcare, ReprodWissen, BioSilu and ZIVA. S.T. and B.C. are employees of IBSA.

Trial registration number: NCT00827983 and NCT00828191 (clinicaltrials.gov).

Trial registration date: 23 January 2009 (NCT00827983 and NCT00828191).

Date of first patient’s enrolment: January 2009 (NCT00827983 and NCT00828191).

Keywords: IVF; IVF outcome; endometrial thickness; endometrium; pregnancy rates; thin endometrium.

Figures

Figure 1
Figure 1
Distribution of patients by endometrial thickness on the day of embryo transfer. Mean (±SD) and median endometrial thickness were 11.08 (±2.40) and 10.90, respectively.
Figure 2
Figure 2
Ongoing pregnancy rates by percentiles of endometrial thickness. The error bars show the 95% CIs.
Figure 3
Figure 3
Odds ratios with 95% CIs for ongoing pregnancy achievement for different cut-offs of endometrial thickness. OR = odds ratio; EMT = endometrial thickness.

References

    1. Alcazar JL. Three-dimensional ultrasound assessment of endometrial receptivity: a review. Reprod Biol Endocrinol 2006;9:56.
    1. Azumaguchi A, Henmi H, Saito M, Itabashi E. Role of dilatation and curettage in the etiology of thin endometrium. Hum Reprod 2011;26:i11–i14. 10.1093/humrep/26.s1.6.
    1. Baker VL, Jones CA, Doody K, Foulk R, Yee B, Adamson GD et al. . A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Hum Reprod 2014;29:2212–2220.
    1. Barker MA, Boehnlein LM, Kovacs P, Lindheim SR. Follicular and luteal phase endometrial thickness and echogenic pattern and pregnancy outcome in oocyte donation cycles. J Assist Reprod Genet 2009;26:243–249.
    1. Bozdag G, Esinler I, Yarali H. The impact of endometrial thickness and texture on intracytoplasmatic sperm injection outcome. J Reprod Med 2009;5:303–311.
    1. Bu Z, Sun Y. The impact of endometrial thickness on the day of human chorionic gonadotrophin (hCG) administration on ongoing pregnancy rate in patients with different ovarian response. PLoS One 2015;10:e0145703.
    1. Check JH, Choe JK, Summers-Chase D. Failure to increase the thickness of thin endometria with intrauterine infusion of granulocyte colony stimulating factor(G-CSF). Clin Exp Obstet Gynecol 2016;43:332–333.
    1. Chen SL, Wu FR, Luo C, Chen X, Shi XY, Zheng HY, Ni YP. Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study. Reprod Biol Endocrinol 2010;8:30.
    1. Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet 2006;23:337–342.
    1. De Geyter C, Schmitter M, De Geyter M, Nieschlag E, Holzgreve W, Schneider HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1.186 infertile women. Fertil Steril 2000;1:106–113.
    1. Dechaud H, Bessueille E, Bousquet PJ, Reyftmann L, Hamamah S, Hedon B. Optimal timing of ultrasonographic and Doppler evaluation of uterine receptivity to implantation. Reprod Biomed Online 2008;3:368–375.
    1. Dietterich C, Check JH, Choe JK, Nazari A, Lurie D. Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer. Fertil Steril 2002;4:781–786.
    1. Doblinger J, Cometti B, Trevisan S, Griesinger G. Subcutaneous progesterone is effective and safe for luteal phase support in IVF: an individual patient data meta-analysis of the phase III trials. PLoS One 2016;11:e0151388.
    1. Jarvela IY, Sladkevicius P, Kelly S, Ohja K, Campbell S, Nargund G. Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol 2005;7:765–769.
    1. Kasius A, Smit JG, Torrance HL, Eijkemans MJ, Mol BW, Opmeer BC, Broekmans FJ. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update 2014;20:530–541.
    1. Kuc P, Kuzcynska A, Topczewska M, Tadejko P, Kuczynski W. The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes. Gynecol Endocrinol 2011;11:867–873.
    1. Lockwood G, Griesinger G, Cometti B. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Fertil Steril 2014;101:112–119.
    1. Nakagawa K, Ojiro Y, Jyuen H, Nishi Y, Sugiyama R, Kuribayashi Y, Sugiyama R. Prostaglandin therapy during the proliferative phase improves pregnancy rates following frozen embryo transfer in a hormone replacement cycle. J Obstet Gynaecol Res 2014;40:1331–1337.
    1. Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. The role of endometrial and subendometrial blood flows measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during IVF treatment. Hum Reprod 2006;1:164–170.
    1. Rashidi BH, Sadeghi M, Jafarabadi M, Tehrani Nejad ES. Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern. Eur J Obstet Gynecol Reprod Biol 2005;2:179–184.
    1. Schild RL, Knobloch C, Dorn C, Fimmers R, Ven H, Hansmann M. Endometrial receptivity in an in vitro fertilization program as assessed by spiral arterial blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow. Fertil Steril 2001;2:361–366.0.
    1. Singh N, Bahadur A, Mittal S, Malhotra N, Bhatt A. Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D doppler in in-vitro fertilization cycles: a prospective clinical study from a tertiary care unit. J Hum Reprod Sci 2011;4:29–33.
    1. Wang L, Qiao J, Li R, Zhen X, Liu Z. Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF-ET cycles. Reprod Biol Endocrinol 2010;8:122.
    1. Xu B, Zhang Q, Hao J, Xu D, Li Y. Two protocols to treat thin endometrium with granulocyte colony-stimulating factor during frozen embryo transfer cycles. Reprod Biomed Online 2015;30:349–358.
    1. Yuan X, Saravelos SH, Wang Q, Xu Y, Li TC, Zhou C. Endometrial thickness as a predictor of pregnancy outcomes in 10787 fresh IVF-ICSI cycles. Reprod Biomed Online 2016;33:197–205.
    1. Zhao J, Zhang Q, Li Y. The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reprod Biol Endocrinol 2012;10:100.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner